KoreInside Blogs

March 14, 2022

KoreClient Spotlight: Peter Kassel, CEO and Co-Founder of HealthySole

Peter Kassel is the CEO and co-founder of Healthysole, a remover of 99.99% of infectious bacteria, viruses, and spores that are tracked on your shoes. As the co-founder of HealthySole Peter has been with the company for its entire journey, which began in 2011. We recently sat down with Peter to discuss his company, the […]

March 11, 2022

KoreClient Spotlight: Dr. Joseph McGinley, Founder and CEO of McGinley Orthopedics

Joseph C. McGinley. M.D., Ph.D. is a highly accomplished musculoskeletal intervention and sports medicine physician with over 15 years of experience in the field. He holds a Bachelor’s and Master’s Degree in Mechanical Engineering and a Ph.D. in Physiology and an MD from Temple University. He completed both his residency and fellowship at Stanford University. […]

March 9, 2022

What are the Benefits of a Cap Table in Capital Raising?

If you’re running a business, then you know that keeping track of your finances is essential. And if you’re looking to raise money from investors, then you’ll need to create a cap table. But what is a cap table, and what are the benefits of having one? In this blog post, we’ll answer those questions […]

March 7, 2022

Secondary Market Trading for RegA+, RegCF, and RegD

As more and more companies look to raise capital in the private capital market, it’s essential to understand the different exemptions available for this purpose. In this blog post, we’ll look at three common types of capital raises; Reg A+, Reg CF, and Reg D. We’ll discuss the critical differences between each one and how […]

March 4, 2022

How to Ensure Your Marketing is Compliant During an Equity Crowdfunding Raise

You may be wondering, “Why is a marketing agency talking about compliance?”. We’re obviously not lawyers, but it is pivotal that compliance is offered at the forefront of your marketing planning. Now we are not soliciting any legal or financial advice today. The purpose of the webinar is to give you a good introduction to […]

March 2, 2022

KoreClient Spotlight: Brent Fawson, COO of Facible

Working at Facible, Brent Fawson believes that the company is poised to leave a lasting impact on lives around the world by making medical diagnostic testing more accessible. We sat down with Brent and talked to him about the medical industry, his company, and capital raising in the medical field.   Q: Tell me a […]

February 28, 2022

Attracting Impact Investors

Founders and executives of startup and early-stage healthcare companies seeking funding historically were limited to appeals to Venture Capital firms, Angels, and bootstrapping – struggling to survive by internal growth alone. In many cases, the founders resort to selling their businesses for values well below their potential. Fortunately, their options have increased due to 1. The […]

February 23, 2022

KoreConX and Medtech-Ecosystem Together at LSI Emerging Medtech Summit 2022

Experts in the life sciences sector will teach investors how to use Regulation A+ for successful capital raising   NEW YORK, February 23, 2022 – KoreConX is thrilled to announce its participation at LSI Emerging Medtech Summit – USA 2022. This event will be held on March 15-18, 2022, in Dana Point, California, USA. It […]

February 21, 2022

Three Trends that We predict Will Shape Investment Crowdfunding in 2022

This article was written by Erin Holloway, KorePartner from Prime Trust. It was originally published on Crowdfund Insider, view the original article here.   Investment crowdfunding took off when the JOBS Act regulation went into effect back in 2016 and has become a booming industry in short order. We saw some significant regulatory changes in March of this […]

February 18, 2022

Can I Use My IRA for Private Company Investments?

Individual retirement accounts (commonly shortened to IRAs) allow flexibility and diversity when making investments. Whether investing in stocks, bonds, real estate, private companies, or other types of investments, IRAs can be useful tools when saving for retirement. While traditional IRAs limit investments to more standard options, such as stocks and bonds, a self-directed IRA allows […]

February 17, 2022

KoreClient Spotlight: Manny Villafaña, CEO and Founder of Medical21

Manny Villafaña has a long track record of innovation in the medtech space, delivering solutions to improve cardiac care and surgical procedures. In his latest venture, Manny is creating a product that will change the way cardiac bypass surgeries are performed, improving patient outcomes.   We sat down with Manny to discuss his company, the […]

February 16, 2022

Why is Your Community of Investors Important?

When companies begin the capital raising journey, it is no longer about going public or simply getting a company’s product in front of venture capitalists. To be successful in our current capital raising landscape with Regulations A+ and CF, organizations must build a community of investors. This not only brings life to your business, but […]

February 14, 2022

How to be Ready for Raising Capital

Whether you’ve raised capital in the past or are preparing for your first round, being properly prepared will help your company secure the funding it needs. Proper preparation will make investors confident that you are ready for their investments and have a foundation in place for the growth and development of your company. So if […]

February 11, 2022

What is Rule 12(g)?

Rule 12(g) is a crucial rule that affects all issuers, but many issuers don’t start with it in mind. The rule began with the 1934 Exchange Act, and it states the threshold at when an issuer must register securities with the SEC. Read further to learn what rule 12(g) does and why it’s essential.   […]

February 8, 2022

KoreConX and David Weild IV at LSI Emerging Medtech Summit 22

‘Father of the JOBS Act,’ Mr. Weild will join KoreConX to address a keynote on how Medtech is the new frontier to a successful capital raising NEW YORK, February 8, 2022 – KoreConX and its partner, Life Science Intelligence, are bringing together top thought leaders in the private capital markets environment to the Emerging Medtech […]

February 7, 2022

What is Regulation S?

It is essential to be familiar with the different regulations that govern how companies can raise capital in today’s business world. One important rule is Regulation S. This article will give you a basic overview of Regulation S, how it affects businesses, and how companies can use it to raise capital.   What is Regulation […]

February 4, 2022

KorePartner Spotlight: Scott Pantel, President & CEO of Life Science Intelligence

With the launch of the KoreConX all-in-one platform, KoreConX is happy to feature the partners contributing to its ecosystem.    During the capital raising journey, many things must be in place to increase the potential for success. One of these critical factors is having the right team to assist with gaining information on your demographic […]

February 2, 2022

The Recipe for a Successful RegA+ Offering

If your company is looking to raise funding, you’ve probably considered many options for doing so. Since the SEC introduced the outlines for Regulation A+ in the JOBS Act in 2012 and its subsequent amendments, companies are able to raise amounts up to $75 million during rounds of funding from both accredited and non-accredited investors alike. […]

January 31, 2022

How to Read a Startup’s Financial Statements

This article was originally written by our KorePartners at StartEngine. View the original post here.   When considering which startups to invest in, there is some key information prospective investors would want to review and understand before making any investment decision. A lot of the information is presented to you on campaign pages, but if […]

January 28, 2022

What is Regulation A+?

Regulation A+ (RegA+) was passed into law by the SEC in the JOBS Act, making it possible for companies to raise funding from the general public and not just from accredited investors. Since March 2021, companies have been able to take advantage of the limit’s increase to $75 million. This provides companies the ability to […]